Purchases and Sales Made in Q4 2023 in Krystal Biotech, Inc. (KRYS)
This table provides information about the institutional ownership of Krystal Biotech, Inc. (KRYS) during Q4 2023. The information is specifically focused on institutions that hold shares of Krystal Biotech, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2024
Q4 2023
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-7.15K- 4.27% |
$686K - $917K
|
160K
$28.2M
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-7.97K- 3.6% |
$766K - $1.02M
|
214K
$37.6M
|
|
Feb 13, 2024
Q4 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-8.16K- 62.21% |
$783K - $1.05M
|
4.95K
$873K
|
|
Jan 31, 2024
Q4 2023
|
Calamos Advisors LLC
|
SELL
|
- |
-9.94K- 38.76% |
$954K - $1.28M
|
15.7K
$2.77M
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-12.4K- 62.19% |
$1.19M - $1.6M
|
7.56K
$1.33M
|
|
Feb 05, 2024
Q4 2023
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-13.2K- 34.16% |
$1.27M - $1.7M
|
25.5K
$4.49M
|
|
Feb 14, 2024
Q4 2023
|
Candriam S.C.A.
|
SELL
|
- |
-15K- 21.43% |
$1.44M - $1.92M
|
55K
$9.69M
|
|
Jan 10, 2024
Q4 2023
|
Hennion & Walsh Asset Management, Inc.
|
SELL
|
- |
-19.4K- 38.22% |
$1.86M - $2.49M
|
31.4K
$5.53M
|
|
Feb 14, 2024
Q4 2023
|
Sei Investments CO
Oaks, PA |
SELL
|
- |
-20.1K- 57.64% |
$1.93M - $2.58M
|
14.8K
$2.6M
|
|
Feb 14, 2024
Q4 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-24.5K- 32.62% |
$2.35M - $3.14M
|
50.6K
$8.92M
|
|
Feb 14, 2024
Q4 2023
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-28K- 25.72% |
$2.69M - $3.59M
|
80.8K
$14.2M
|
|
Feb 14, 2024
Q4 2023
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-29.8K- 84.64% |
$2.86M - $3.82M
|
5.41K
$953K
|
|
Feb 14, 2024
Q4 2023
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-30K- 37.5% |
$2.88M - $3.85M
|
50K
$8.81M
|
|
Feb 14, 2024
Q4 2023
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-31.1K- 24.48% |
$2.99M - $3.99M
|
96K
$16.9M
|
|
Feb 13, 2024
Q4 2023
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-32.5K- 56.52% |
$3.12M - $4.17M
|
25K
$4.4M
|
|
Feb 05, 2024
Q4 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-36.6K- 17.48% |
$3.51M - $4.7M
|
173K
$30.5M
|
|
Feb 12, 2024
Q4 2023
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-52.9K- 7.87% |
$5.07M - $6.78M
|
618K
$109M
|
|
Oct 07, 2024
Q4 2023
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-52.9K- 7.87% |
$5.07M - $6.78M
|
618K
$109M
|
|
Feb 14, 2024
Q4 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-58.1K- 69.43% |
$5.57M - $7.45M
|
25.6K
$4.5M
|
|
Feb 14, 2024
Q4 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-77.9K- 66.07% |
$7.48M - $9.99M
|
40K
$7.05M
|
|
Feb 13, 2024
Q4 2023
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-181K- 48.4% |
$17.4M - $23.2M
|
193K
$34M
|
|
Feb 07, 2024
Q4 2023
|
Nicholas Investment Partners, LP
Rancho Santa Fe, CA |
SELL
|
- |
-307K- 86.2% |
$29.4M - $39.3M
|
49.1K
$8.65M
|
|
Feb 14, 2024
Q4 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-683K- 97.81% |
$65.6M - $87.6M
|
15.3K
$2.7M
|
|
Feb 14, 2024
Q4 2023
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-833K- 32.47% |
$80M - $107M
|
1.73M
$305M
|